FDA inspection
Nippon Kayaku Co., Ltd.: FDA inspection ending May 29, 2026
FDA inspection 1323474 · Voluntary Action Indicated (VAI) · Takasaki
Key facts
| Inspection ID | 1323474 |
|---|---|
| Firm | Nippon Kayaku Co., Ltd. |
| FEI number | 3002807722 |
| Address | 239, Iwahana-Machi |
| City | Takasaki |
| Country | Japan |
| Fiscal year | 2026 |
| Inspection end date | May 29, 2026 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data